GlassScriptPhysician profile
James R Jackson
NPI 1871648253
$832.80
in general payments reported to CMS, 2019-2025
14 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $161 · 2022: $159 · 2023: $261 · 2024: $98.78 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $334.86 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $109.64 | 2021-2023 | Invega Sustenna |
| Lundbeck LLC | $77.90 | 2023-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $64.21 | 2022-2025 | |
| Tris Pharma INC | $39.79 | 2024-2025 | Dyanavel Xr |
| Idorsia Pharmaceuticals US INC | $38.17 | 2023-2024 | Quviviq |
| Alkermes, INC. | $36.25 | 2022-2025 | Aristada, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $32.08 | 2022-2024 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $19.09 | 2021 | |
| Acadia Pharmaceuticals INC | $18.70 | 2022 | |
| Ironshore Pharmaceuticals INC. | $17.69 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.85 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $15.79 | 2022 | |
| Corium, LLC | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.